ClariVest Asset Management’s Immunomedics Inc IMMU Stock Holding History

ClariVest Asset Management’s Portfolio IMMU Stock Details IMMU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-11	Closed	-$1K	–	856
2020 Q3	$1K	Sell	11 -64,889	-100%	-$3.28M	﹤0.01%	738
2020 Q2	$2.3M	Sell	64,900 -54,863	-46%	-$1.6M	0.06%	212
2020 Q1	$1.61M	Buy	119,763 +162	+0.1%	+$2.73K	0.05%	225
2019 Q4	$2.53M	Sell	119,601 -80,359	-40%	-$1.42M	0.06%	221
2019 Q3	$2.65M	Sell	199,960 -2,600	-1%	-$38.2K	0.06%	221
2019 Q2	$2.81M	Buy	+202,560	New	+$3.05M	0.06%	217

ClariVest Asset Management's IMMU Position: Q4 2020 in Review

ClariVest Asset Management sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 11 shares — an estimated $1K sold.

ClariVest Asset Management first reported a position in IMMU in Q2 2019 and held it in 6 quarters. The position peaked at $2.81M in Q2 2019. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.

ClariVest Asset Management reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
ClariVest Asset Management sold 11 Immunomedics Inc shares in Q4 2020, an estimated $1K.
ClariVest Asset Management first reported a position in Immunomedics Inc in Q2 2019 and held it in 6 quarters.
ClariVest Asset Management's Immunomedics Inc position peaked at $2.81M in Q2 2019.
0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.

Based on ClariVest Asset Management's 13F filing for Q4 2020, filed 9 Feb 2021.